Related Experiment Video
Updated: Jun 2, 2026
07:44
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
Published on: May 12, 2023
Vaccination, consent and multidose vials
Mark R Diamond1, Angela O'Brien-Malone
1School of Psychology, University of Tasmania, Hobart, TAS. diamondm@utas.edu.au
The Medical Journal of Australia
|April 19, 2011
Summary
Multidose vials (MDVs) increase infection risk for patients receiving injectable medications. Current consent forms inadequately address these risks, potentially exposing healthcare providers to negligence claims.
Area of Science:
- Infectious Disease Prevention
- Patient Safety
- Healthcare Law
Background:
- Multidose vials (MDVs) for injectable therapeutics, including vaccines, present a risk of patient infection due to vial contamination.
- The Australian Government Department of Health and Ageing (DoHA) distributed pandemic (H1N1) 2009 influenza vaccine in MDVs, highlighting this risk.
- Inadequate consent forms were provided with these MDVs, failing to fully inform patients of associated risks.
Purpose of the Study:
- To evaluate the adequacy of consent forms used for multidose vial (MDV) vaccine distribution.
- To highlight the legal implications for medical practitioners regarding informed consent for MDV use.
- To advocate for improved consent processes to mitigate risks associated with MDVs.
Main Methods:
- Review of consent forms used for pandemic (H1N1) 2009 influenza vaccine distributed in multidose vials (MDVs).
- Analysis of Australian legal precedents concerning medical practitioner liability for failure to disclose material risks.
- Assessment of the adequacy of informed consent in the context of multidose vial administration.
Main Results:
- Consent forms provided for the pandemic (H1N1) 2009 influenza vaccine distributed in multidose vials (MDVs) were insufficient for a comprehensive discussion of risks.
- Existing legal frameworks indicate potential negligence claims against medical practitioners for inadequate risk disclosure.
- The use of MDVs necessitates a more robust informed consent process.
Conclusions:
- Medical practitioners, nurses, and health authorities must develop improved consent forms for multidose vial (MDV) use.
- Enhanced consent forms are crucial for adequately informing patients about the material risks of injectable therapeutic agents from MDVs.
- Proactive development of comprehensive consent procedures is essential to prevent infection risks and address potential legal liabilities.
Related Concept Videos
01:51Vaccinations
Overview
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:28Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...